Nicorandil

Chemical formula: C₈H₉N₃O₄  Molecular mass: 211.177 g/mol  PubChem compound: 47528

Therapeutic indications

Nicorandil is indicated for:

Stable angina pectoris

Population group: only adults (18 years old or older)

Nicorandil is indicated in adults for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or have a contraindication or intolerance to first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Nicorandil is contraindicated in the following cases:

Acute pulmonary oedema

Acute pulmonary edema

Hypovolaemia

Acute kidney injury due to hypovolaemia

Riociguat

Riociguat

Phosphodiesterase 5 inhibitors

PDE5 selective inhibitors

Shock, severe hypotension, left ventricular dysfunction

at least one of
Shock
Hypotension
Left ventricular systolic dysfunction

Hypersensitivity to nicorandil

Nicorandil allergy

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2021: IKOREL Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈